Where Does Rhythm Pharmaceuticals Inc (RYTM) Stock Fall in the Biotechnology Field After It Is Higher By 1.45% This Week?

Rhythm Pharmaceuticals Inc (RYTM) is near the top in its industry group according to InvestorsObserver. RYTM gets an overall rating of 68. That means it scores higher than 68 percent of stocks. Rhythm Pharmaceuticals Inc gets a 85 rank in the Biotechnology industry. Biotechnology is number 53 out of 148 industries.

RYTM has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on RYTM!

See Full RYTM Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Rhythm Pharmaceuticals Inc Stock Today?

Rhythm Pharmaceuticals Inc (RYTM) stock is trading at $34.31 as of 11:42 AM on Monday, Nov 27, a loss of -$0.33, or -0.95% from the previous closing price of $34.64. The stock has traded between $33.85 and $34.54 so far today. Volume today is less active than usual. So far 79,324 shares have traded compared to average volume of 586,454 shares. Click Here to get the full Stock Report for Rhythm Pharmaceuticals Inc stock.